- Home
- COLL vs SXC Comparison
COLL vs SXC Comparison
Compare COLL & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- SXC
- Stock Information
- Founded
- COLL 2002
- SXC 1960
- Country
- COLL United States
- SXC United States
- Employees
- COLL N/A
- SXC N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- SXC Steel/Iron Ore
- Sector
- COLL Health Care
- SXC Industrials
- Exchange
- COLL Nasdaq
- SXC Nasdaq
- Market Cap
- COLL 910.2M
- SXC 802.2M
- IPO Year
- COLL 2015
- SXC N/A
- Fundamental
- Price
- COLL $27.38
- SXC $8.20
- Analyst Decision
- COLL Strong Buy
- SXC Strong Buy
- Analyst Count
- COLL 5
- SXC 1
- Target Price
- COLL $43.60
- SXC $13.00
- AVG Volume (30 Days)
- COLL 449.2K
- SXC 927.5K
- Earning Date
- COLL 05-08-2025
- SXC 04-30-2025
- Dividend Yield
- COLL N/A
- SXC 5.90%
- EPS Growth
- COLL 43.56
- SXC 64.98
- EPS
- COLL 1.86
- SXC 1.12
- Revenue
- COLL $631,449,000.00
- SXC $1,935,400,000.00
- Revenue This Year
- COLL $20.00
- SXC N/A
- Revenue Next Year
- COLL $3.93
- SXC $3.70
- P/E Ratio
- COLL $14.75
- SXC $7.39
- Revenue Growth
- COLL 11.41
- SXC N/A
- 52 Week Low
- COLL $26.64
- SXC $7.47
- 52 Week High
- COLL $42.29
- SXC $12.82
- Technical
- Relative Strength Index (RSI)
- COLL 31.13
- SXC 30.68
- Support Level
- COLL $29.01
- SXC $8.92
- Resistance Level
- COLL $30.53
- SXC $9.30
- Average True Range (ATR)
- COLL 0.86
- SXC 0.25
- MACD
- COLL -0.23
- SXC -0.06
- Stochastic Oscillator
- COLL 5.31
- SXC 17.30
Stock Price Comparison Chart: COLL vs SXC
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers.